Cargando…
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
The diagnosis of Multiple Myeloma is a challenge to the physician due to the non-specific symptoms (anemia, bone pain and recurrent infections) that are commonplace in the elderly population. However, early diagnosis is associated with less severe disease, including fewer patients presenting with ac...
Autores principales: | Tietsche de Moraes Hungria, Vania, Allen, Syreeta, Kampanis, Petros, Soares, Elyara Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786779/ https://www.ncbi.nlm.nih.gov/pubmed/26969773 http://dx.doi.org/10.1016/j.bjhh.2015.11.003 |
Ejemplares similares
-
Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy
por: Kim, Han-Sung, et al.
Publicado: (2014) -
Comment on “Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy”
por: Parker, Antony R., et al.
Publicado: (2015) -
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
por: Napodano, Cecilia, et al.
Publicado: (2023) -
Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018) -
Crystal‐storing histiocytosis associated with monoclonal kappa light chain gammopathy
por: Lesesve, Jean‐François, et al.
Publicado: (2022)